Children who have irritable bowel syndrome associated with constipation (IBS-C) and abdominal pain may qualify for a clinical study with Meridian Clinical Research. This study will gather additional information about the safety and effectiveness of a medication that is currently approved for use by adults with IBS-C.

All study-related office visits, study medications, lab work, and study procedures are provided at no cost to participants. This is a placebo-controlled study — some participants will receive a non-active placebo.

• Must be age age 6-17
• Must have had the following symptoms for at least 2 months; Abdominal pain at least 4 days per month associated with one or more of the following:
  • Related to defecation
  • A change in frequency of stool
  • A change in form (appearance) of stool
• Will receive compensation for study-related time
• Do not need insurance to join this study